About
LuxMed Systems, Inc. is the leader in second-generation, sensor-based pulsed field ablation (PFA) and radiofrequency therapeutic cardiac ablation and opto-anatomical mapping, enabling unprecedented real-time assessment of lesion quality, durability and gap detection. The resultant clinical value proposition is improved lesion durability and reduced recurrence rates which will substantially benefit patients, hospital systems and payors.
Technologies
OutlookCedexis RadarWeeblyAdobe Media OptimizerGoogle Font APIreCAPTCHAGoogle AnalyticsMobile FriendlyVimeoAI
Keywords
optical tissue interrogation during ablationmetabolic activitylesion and gap detectiontissue viabilityreal-time lesion monitoringhealthcare technologycatheter movement trackingcatheter contact stabilitypfa ablationoptical tissue interrogationoptical assessment of tissue contactelectroporationmetabolic tissue signaturesip portfoliob2bclinical datalesion formationoptical assessmentcatheter movementlife scienceslesion detectionadvanced electrophysiology toolsablation cathetermetabolic activity monitoringanimal model testingmedical devicesrf ablationoptically enabled rf catheterscardiovascular devicesmedical equipment and supplies manufacturing
Company Information
- Employees15
- Founded2019
Location
Cambridge, Massachusetts, United States
